ArticleClinical pharmacokinetics2022

Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.

Lénaïg Tanneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.